Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
NCT: NCT06583876 · RECRUITING
Brief Summary
The purpose of this study is to evaluate the safety and feasibility of the Bio Refine Coriofix System and determine if it might help in treatment of functional mitral regurgitation. The study will include patients with symptomatic secondary mitral regurgitation in whom mitral surgery cannot and/or will not be offered as a treatment option (the risk is prohibitive). Potential patients will be screened to confirm that all inclusion/exclusion criteria are met, with final eligibility confirmation on day of procedure. All enrolled subjects who went through the procedure will be followed during the procedure to hospital discharge. Additional follow up time points are scheduled at 30 days, 6 months and 12 months post procedure.
Frequently Asked Questions
What is Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study?
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study is a clinical trial registered under NCT06583876. Current status: RECRUITING.
What is the status of NCT06583876?
The current status of NCT06583876 (Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study) is: RECRUITING.
When did Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study start?
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study started on 2024-06-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.